( July 17, 2026, 2:09 PM EDT) -- WASHINGTON, D.C. — EyePoint Inc. has agreed to pay the U.S. government $4,657,463.18 to resolve a suit filed in federal court in Massachusetts alleging that it violated the False Claims Act (FCA) by paying kickbacks to certain ambulatory surgery centers to induce them to purchase and dispense DEXYCU, an injectable drug approved for the treatment of ocular inflammation after cataract surgery, the Department of Justice announced July 17 in a news release....